Federated Hermes
TNDM icon

Federated Hermes’s Tandem Diabetes Care TNDM Stock Holding History

Federated Hermes’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Hold
123,819
– – ﹤0.01% 1024
2026
Q1 		$2.37M Buy
123,819
+123,794
+495,176% +$2.69M ﹤0.01% 939
2025
Q4 		$550 Buy
+25
New +$451 ﹤0.01% 2045
2023
Q1 		– Sell
-10,236
Closed -$460K – 2259
2022
Q4 		$460K Sell
10,236
-653,104
-98% -$29.6M ﹤0.01% 1392
2022
Q3 		$31.7M Sell
663,340
-477,772
-42% -$26.2M 0.09% 277
2022
Q2 		$67.5M Sell
1,141,112
-59,482
-5% -$4.88M 0.18% 149
2022
Q1 		$140M Buy
1,200,594
+890
+0.1% +$104K 0.32% 77
2021
Q4 		$181M Buy
1,199,704
+40,966
+4% +$5.53M 0.34% 73
2021
Q3 		$138M Sell
1,158,738
-115,090
-9% -$12.7M 0.26% 100
2021
Q2 		$124M Buy
1,273,828
+28
+0% +$2.5K 0.23% 113
2021
Q1 		$112M Sell
1,273,800
-125
-0% -$11.6K 0.22% 128
2020
Q4 		$122M Sell
1,273,925
-30,809
-2% -$3.18M 0.25% 101
2020
Q3 		$148M Sell
1,304,734
-44,598
-3% -$4.69M 0.35% 63
2020
Q2 		$133M Sell
1,349,332
-77,569
-5% -$6.19M 0.33% 63
2020
Q1 		$91.8M Sell
1,426,901
-31,440
-2% -$2.2M 0.27% 80
2019
Q4 		$86.9M Sell
1,458,341
-55,992
-4% -$3.45M 0.19% 119
2019
Q3 		$89.3M Sell
1,514,333
-26,482
-2% -$1.69M 0.22% 103
2019
Q2 		$99.4M Sell
1,540,815
-60,262
-4% -$3.89M 0.24% 92
2019
Q1 		$102M Sell
1,601,077
-108,955
-6% -$5.72M 0.25% 81
2018
Q4 		$64.9M Buy
1,710,032
+101,631
+6% +$3.59M 0.18% 119
2018
Q3 		$68.9M Sell
1,608,401
-1,048,099
-39% -$36.6M 0.16% 143
2018
Q2 		$58.5M Buy
2,656,500
+406,224
+18% +$5M 0.17% 117
2018
Q1 		$11.2M Buy
2,250,276
+2,249,961
+714,273% +$7.25M 0.03% 397
2017
Q4 		$1K Sell
315
-143
-31% -$449 ﹤0.01% 2131
2017
Q3 		$3K Sell
458
-267
-37% -$1.69K ﹤0.01% 2026
2017
Q2 		$6K Buy
725
+32
+5% +$296 ﹤0.01% 1923
2017
Q1 		$8K Buy
693
+468
+208% +$10.2K ﹤0.01% 1860
2016
Q4 		$5K Buy
+225
New +$8.66K ﹤0.01% 1940

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Federated Hermes's TNDM Position: Q2 2026 in Review

Federated Hermes held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 123,819 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Federated Hermes first reported a position in TNDM in Q4 2016 and has held it in 28 quarters since. The position peaked at $181M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Federated Hermes held 123,819 shares of Tandem Diabetes Care worth $1.87M as of Q2 2026.
  • Federated Hermes left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1024 holding.
  • Federated Hermes first reported a position in Tandem Diabetes Care in Q4 2016 and has held it in 28 quarters since.
  • Federated Hermes's Tandem Diabetes Care position peaked at $181M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.